View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Pfizer proposes $101 billion takeover to AstraZeneca, reports claim

April 28, 2014
U.S. pharmaceutical company Pfizer has expressed interest in taking over Anglo-Swedish giant AstraZeneca for a total of $101 billion.
Read More

Lupin recalls 9,000 bottles of antibiotic drug

April 21, 2014
Two lots of Suprax, an antibiotic drug used to treat bacterial infections, are being withdrawn from the U.S. market because the product does not meet federal standards for impurities.
Read More

US, EU generic drug makers call for regulatory cooperation

April 16, 2014
Generic pharmaceuticals manufacturers from Europe and the United States have urged regulators on both sides of the Atlantic to adopt a strategy of "regulatory convergence."
Read More

Scientists find benefits of Tamiflu overestimated

April 14, 2014
A new study raises concerns that the effect of the vastly popular influenza treatment drug may have been overestimated.
Read More

US demand for pharma excipients to rise 4.3% per year through 2018

April 3, 2014
Excipients in oral formulations, such as tablets and capsules, will be well positioned for strong market performance.
Read More

Horizon Pharma buys Irish drug maker Vidara

March 26, 2014
Illinois-based Horizon Pharma Inc. announced last week it was taking over Irish Vidara Therapeutics International Ltd. in a reverse merger, moving its headquarters to Dublin.
Read More

FDA bans import of drugs from Sun Pharma's Gujarat facility

March 24, 2014
The U.S. FDA has issued an import alert for Indian drug maker Sun Pharmaceuticals Ltd., banning the import of drug products manufactured at the company's facility in Gujarat.
Read More

EU to destroy transit counterfeit drugs

March 10, 2014
The European Union has approved a revision of its trademark legislation, including a provision that allows EU customs to block and destroy counterfeit branded pharmaceutical products, even if they are intended for markets outside the union.
Read More

Endo Pharmaceuticals settles lawsuit over unlawful marketing

February 26, 2014
Pharmaceutical companies Endo Pharmaceuticals and Endo Health Solutions will have to pay $192.7 million to resolve criminal and civil charges related to their marketing policy for the product Lidoderm.
Read More

US, Indian officials meet to discuss drug safety

February 17, 2014
India and the United States have been locked in a regulatory conflict over generic pharmaceutical products distributed on the U.S. market.
Read More